Their flagship product, Carevix, is a suction cervical stabilizer that replaces traumatic forceps to prevent cervix bleeding and reduce pain (-55%) and bleeding (-90%) associated with transcervical procedures commonly performed in gynecology, such as IUD insertion. The device is based on a patented suction pad technology that enables physicians to avoid cervical tear and lacerations, protecting patients from the risk of developing cross-infections. The company aims to modernize gynecology by providing a safer and more comfortable experience for women undergoing gynecological procedures. The commercial release of Carevix is expected in 2023 in the USA and selected European markets.